2017 Compounds in Comp: A New Look at Patient Safety, Efficacy and Cost

2017 Compounds in Comp: A New Look at Patient Safety, Efficacy and Cost (PDF)

CompPharma published “Compounding is Confounding Workers’ Compensation” in 2014. That research paper, like this one, was written by pharmacists and government affairs professionals employed by several of the member pharmacy benefit management (PBM) companies of CompPharma. Many of the pharmacists who worked on both papers have extensive training and experience in the art of pharmaceutical compounding.

The original paper was well received by the workers’ compensation community, and over 2,000 copies have been downloaded from the CompPharma website as well as those of the member companies. In addition, the paper was presented at several industry forums including the International Association of Industrial Accident Boards and Commissions (IAIABC) and the American Insurance Association (AIA).

However, the paper was not well received by a few pharmacists who interpreted it as an attack on both the necessity and the science of state-of-the-art pharmaceutical compounding